Literature DB >> 33352095

Inappropriate Utilization of Antibiotics in COPD Exacerbations.

Yelda Varol1, Zuhal Karakurt2, Ali Kadri Çırak1, Hülya Doğan Şahin1, Cenk Kıraklı1, Berna Kömürcüoğlu1.   

Abstract

OBJECTIVE: Most exacerbations are mild to moderate, and antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is recommended for patients with severe exacerbations or severe underlying chronic obstructive pulmonary disease (COPD). Therefore, we aimed to investigate the patient factors that are associated with the prescription of antibiotics for inappropriate indication in AECOPD.
MATERIAL AND METHODS: This study was an observational cross-sectional study conducted in an outpatient clinic. The patients diagnosed with AECOPD and prescribed an antibiotic by a pulmonary physician were enrolled in the study. These prescriptions were documented by the pharmacist who asked the patient about the three cardinal symptoms. Appropriate and inappropriate prescription groups were defined by the types of exacerbations, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD report.
RESULTS: There were 138 patients, predominantly male (83%), with a mean age of 64 (±9) years. A total of 64% of the prescriptions were appropriate; however, there were 50 (36%) patients with inappropriate antibiotic prescription according to the mentioned criteria. When we compared the patient factors between the appropriate and inappropriate antibiotic prescriptions, there was no statistically significant difference in terms of age, Forced expiratory volume in first second % (FEV1%) predicted, FEV1 ml, forced vital capacity (FVC) ml, FEV1/FVC, and amount (packs/year) of smoking (p>0.05 for all parameters). FVC% was statistically significantly lower in the appropriate antibiotic prescription group compared with that in the inappropriate antibiotic prescription group (p=0.049).
CONCLUSION: This study shows that most pulmonary physicians have a tendency to prescribe antibiotics for AECOPD according to the defined GOLD criteria. However, some of the physicians also prefer to prescribe antibiotics self-directedly, irrespective of the GOLD criteria. A physician-based questionnaire can be completed for future studies to define the underlying reasons for antibiotic prescription demands for cases of mild AECOPD.

Entities:  

Year:  2020        PMID: 33352095      PMCID: PMC7752103          DOI: 10.5152/TurkThoracJ.2020.19074

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  23 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

Review 2.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

3.  Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice.

Authors:  A F Jørgensen; J Coolidge; P A Pedersen; K P Petersen; S Waldorff; E Widding
Journal:  Scand J Prim Health Care       Date:  1992-03       Impact factor: 2.581

4.  Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Peter K Lindenauer; Penelope Pekow; Shan Gao; Allison S Crawford; Benjamin Gutierrez; Evan M Benjamin
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

5.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

6.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

7.  Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?

Authors:  Jettie Bont; Eelko Hak; Christine E Birkhoff; Arno W Hoes; Theo J M Verheij
Journal:  Fam Pract       Date:  2007-06-29       Impact factor: 2.267

8.  C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD.

Authors:  Tristan W Clark; Marie-Jo Medina; Sally Batham; Martin D Curran; Surendra Parmar; Karl G Nicholson
Journal:  Eur Respir J       Date:  2014-09-03       Impact factor: 16.671

9.  Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.

Authors:  Al-ani Salwan; Mark Spigt; Johanna Laue; Hasse Melbye
Journal:  BMC Fam Pract       Date:  2015-03-24       Impact factor: 2.497

10.  Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.

Authors:  Gernot G U Rohde; Armin Koch; Tobias Welte
Journal:  BMC Pulm Med       Date:  2015-01-27       Impact factor: 3.317

View more
  1 in total

1.  Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.

Authors:  Chin-Wang Hsu; Chi-Won Suk; Yuan-Pin Hsu; Jer-Hwa Chang; Chung-Te Liu; Shau-Ku Huang; Shih-Chang Hsu
Journal:  Respir Res       Date:  2022-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.